[SARS-CoV-2 vaccines induced immune thrombotic thrombocytopenia].
作者信息
Liu Y M, Wang H Q, Shao Z H
机构信息
Department of Hematology, General Hospital of Tianjin Medical University, Tianjin 300052, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):607-610. doi: 10.3760/cma.j.issn.0253-2727.2021.07.016.
Abstract
摘要
相似文献
1
[SARS-CoV-2 vaccines induced immune thrombotic thrombocytopenia].[严重急性呼吸综合征冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症]
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):607-610. doi: 10.3760/cma.j.issn.0253-2727.2021.07.016.
2
Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.单侧线性紫癜性皮疹预示着新型冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e429-e431. doi: 10.1111/jdv.18014. Epub 2022 Feb 23.
3
Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?新冠病毒mRNA疫苗接种后的免疫性血小板减少症：是因果关系还是因果关联？
Intern Emerg Med. 2022 Jan;17(1):295-297. doi: 10.1007/s11739-021-02778-w. Epub 2021 Jun 7.
4
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
5
VITT with inactivated SARS-CoV-2 vaccine - index case.接种过灭活 SARS-CoV-2 疫苗的 VITT - 首例病例。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2036556. doi: 10.1080/21645515.2022.2036556. Epub 2022 Mar 7.
6
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.继发于 COVID-19 疫苗接种的免疫性血小板减少症。
BMJ Case Rep. 2021 May 31;14(5):e242220. doi: 10.1136/bcr-2021-242220.
7
SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.免疫性血小板减少症儿科患者的新型冠状病毒2型疫苗接种
Pediatr Blood Cancer. 2022 Jul;69(7):e29760. doi: 10.1002/pbc.29760. Epub 2022 May 13.
8
Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.关于先前发表的Epub手稿的通信：新型冠状病毒疫苗接种后免疫性血小板减少性紫癜
Br J Haematol. 2021 Sep;194(6):e93-e95. doi: 10.1111/bjh.17628. Epub 2021 Jun 10.
9
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.新型冠状病毒肺炎疫苗接种后新发和复发性免疫性血小板减少症：法国安全性监测结果
Blood. 2022 Apr 21;139(16):2561-2565. doi: 10.1182/blood.2022015470.
10
Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.对关于先前发表的Epub稿件的通信的回复：新型冠状病毒2疫苗接种后免疫性血小板减少性紫癜
Br J Haematol. 2021 Sep;194(6):e95-e96. doi: 10.1111/bjh.17631. Epub 2021 Jun 25.
引用本文的文献
1
COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.2019冠状病毒病与急性肢体缺血：病理生理学和分子机制的最新假说
J Zhejiang Univ Sci B. 2025 Feb 19;26(4):333-352. doi: 10.1631/jzus.B2300512.
本文引用的文献
1
Prothrombotic immune thrombocytopenia after COVID-19 vaccination.接种 COVID-19 疫苗后的促血栓形成免疫性血小板减少症。
Blood. 2021 Jul 29;138(4):350-353. doi: 10.1182/blood.2021011958.
2
Perspectives on vaccine induced thrombotic thrombocytopenia.疫苗诱导的血栓性血小板减少症的观点。
J Autoimmun. 2021 Jul;121:102663. doi: 10.1016/j.jaut.2021.102663. Epub 2021 May 18.
3
Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology.针对 COVID-19 相关 VITT 的临床和实验室诊断建议：ISTH SSC 血小板免疫学小组委员会的交流。
J Thromb Haemost. 2021 Jun;19(6):1585-1588. doi: 10.1111/jth.15341. Epub 2021 May 20.
4
Vaccine-induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment.疫苗诱导的免疫性血栓性血小板减少症：治疗时考虑静脉注射免疫球蛋白批次。
J Thromb Haemost. 2021 Jul;19(7):1838-1839. doi: 10.1111/jth.15361.
5
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
6
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.对向欧洲药品不良反应数据库报告的新冠阿斯利康疫苗血栓形成不良反应的分析。
Vaccines (Basel). 2021 Apr 16;9(4):393. doi: 10.3390/vaccines9040393.
7
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.美国 2021 年 4 月：在报告接种强生（Johnson & Johnson）新冠疫苗的人群中出现血栓性血小板减少综合征后，免疫实践咨询委员会更新了强生疫苗的使用建议。
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):651-656. doi: 10.15585/mmwr.mm7017e4.
8
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.接种 ChAdOx1 nCoV-19 疫苗后对血小板因子 4 的病理性抗体。
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.
9
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.严重急性呼吸综合征冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症
N Engl J Med. 2021 Jun 10;384(23):2254-2256. doi: 10.1056/NEJMe2106315. Epub 2021 Apr 16.
10
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.疫苗诱导的免疫性血栓性血小板减少症（VITT）：用布鲁顿酪氨酸激酶抑制剂靶向发病机制。
Thromb Haemost. 2021 Nov;121(11):1395-1399. doi: 10.1055/a-1481-3039. Epub 2021 May 28.
Zotero 插件